3B BlackBio Dx has informed that 3B BlackBio Dx (the ‘Company’) interacted one to one with Dalmus Capital Management, Mumbai on Saturday, December 20, 2025 at 13:00 hrs India time. The meeting concluded at 14:00 hrs India time. Further noted that information which is already available in public domain was discussed and no unpublished price sensitive information pertaining to the company was shared with the investor. During this investor meeting, the company reiterated the information shared by it through Investor Presentation of Q2-FY26, which was earlier intimated to the Stock Exchanges vide Ref. No.P66/2025-26/57 dated November 13, 2025. Enclosed the web link of the presentation placed before investors after the declaration of the financial results for the quarter and half year ended 30-09-2025 and the investor. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.bseindia.com/xmldata/corpfiling/AttachHis/351b9755-ddaf-4a3c-967e-07f8f28e5338.pdf.
The above information is a part of company’s filings submitted to BSE.
